| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |